Verteporfin For Injection has 15 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Acetazolamide, Alcohol, Andthiazide. Patients taking Verteporfin For Injection should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 15
- Moderate
- 15
Moderate (15)
- Verteporfin For Injection + Acetazolamide— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Alcohol— Compounds that quench active oxygen species or scavenge radicals would be expected to decrease VISUDYNE activity.
- Verteporfin For Injection + Andthiazide— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Calcium Channel Blockers— Could enhance the rate of VISUDYNE uptake by the vascular endothelium, potentially increasing photodynamic effects.
- Verteporfin For Injection + Dmso— Compounds that quench active oxygen species or scavenge radicals would be expected to decrease VISUDYNE activity.
- Verteporfin For Injection + Formate— Compounds that quench active oxygen species or scavenge radicals would be expected to decrease VISUDYNE activity.
- Verteporfin For Injection + Griseofulvin— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Mannitol— Compounds that quench active oxygen species or scavenge radicals would be expected to decrease VISUDYNE activity.
- Verteporfin For Injection + Mao Inhibitors— Drugs that decrease clotting, vasoconstriction or platelet aggregation could decrease the efficacy of VISUDYNE therapy.
- Verteporfin For Injection + Nonselective Beta-Adrenergic Antagonists— Compounds that quench active oxygen species or scavenge radicals would be expected to decrease VISUDYNE activity.
- Verteporfin For Injection + Phenothiazines— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Polymyxins— Could enhance the rate of VISUDYNE uptake by the vascular endothelium, potentially increasing photodynamic effects.
- Verteporfin For Injection + Sulfonylurea— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Tetracycline— Other photosensitizing agents that could increase the potential for skin photosensitivity reactions.
- Verteporfin For Injection + Thromboxane A2 Inhibitors— Drugs that decrease clotting, vasoconstriction or platelet aggregation could decrease the efficacy of VISUDYNE therapy.